Testicular Germ Cell Tumor Clinical Trial
Official title:
Assessment of the Utility of CT Follow Up in the Long Term Follow Up of Patients With Metastatic Non Seminomatous Germ Cell Tumour (NSGCT)
RATIONALE: Learning about long-term effects in patients with testicular cancer may help
doctors plan better treatment and follow-up care.
PURPOSE: This clinical trial is using CT scans to follow patients who have been treated for
metastatic testicular cancer.
OBJECTIVES:
- To assess the frequency of relapse or recurrent abnormalities detected by CT scan in
patients on long-term follow-up for metastatic nonseminomatous germ cell tumour
(NSGCT).
- To assess the utility of CT scan-assessment in these patients.
- To assess the prognostic factors predictive of late relapse in NSGCT.
OUTLINE: This is a multicenter study.
Patients are screened by CT scan of the chest, abdomen, and pelvis for detectable
abnormalities or indications of late relapse. Scans are classified as positive or negative,
according to standard CT criteria, by a radiologist with expertise in testicular cancer
imaging. Patients with negative scans are followed yearly by clinical examination and tumor
marker assessment, and every 5 years by CT imaging. Additional follow-up is performed at the
discretion of the attending physician. Patients with positive scans undergo confirmation of
relapse, whenever possible, by surgical excision or biopsy and treatment is initiated
according to best clinical practice. If the follow-up scan is equivocal, patients are
advised to have a follow-up scan of the affected region in 6 months.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00788125 -
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT00006126 -
Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery
|
Phase 1 | |
| Completed |
NCT00003173 -
High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors
|
Phase 2 | |
| Completed |
NCT00002596 -
Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
|
Phase 3 | |
| Not yet recruiting |
NCT03448822 -
Sentinel Lymph Node Procedure in Testicular Germ Cell Tumour
|
||
| Completed |
NCT01433224 -
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
|
N/A | |
| Recruiting |
NCT01172912 -
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
|
Phase 2 | |
| Completed |
NCT00293384 -
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
|
N/A | |
| Active, not recruiting |
NCT00003643 -
Combination Chemotherapy in Treating Men With Germ Cell Cancer
|
Phase 2/Phase 3 | |
| Completed |
NCT00003107 -
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
|
Phase 1 | |
| Completed |
NCT00019331 -
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
|
Phase 2 | |
| Completed |
NCT00002515 -
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
|
Phase 2 | |
| Recruiting |
NCT06133699 -
Sentinel Lymph Node Biopsy in Stage AI-IIA Germ Cell Tumors
|
N/A | |
| Recruiting |
NCT05670938 -
Follow-up After Surgery for Testicular Cancer
|
||
| Active, not recruiting |
NCT00104676 -
Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors
|
Phase 3 | |
| Recruiting |
NCT00551122 -
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT00002508 -
Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT00003800 -
Diagnostic Study of Patients With Stage I Testicular Cancer
|
N/A | |
| Terminated |
NCT05012397 -
Milademetan in Advanced/Metastatic Solid Tumors
|
Phase 2 | |
| Completed |
NCT00007813 -
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
|
Phase 1 |